insights_auto
Why is SABS down 2.92%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
$2.99
arrow_downward
-2.92%(-0.090) 1D
Nov 13, 2:48:53 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
$3.08
High
$3.15
Low
$2.85
Mkt. cap
269.37M
Avg. vol.
700.24K
Volume
370.60K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
Open
$3.08
High
$3.15
Low
$2.85
Mkt. cap
269.37M
Avg. vol.
700.24K
Volume
370.60K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
News stories
From web sources and news partners
ChartMill
·
51 minutes ago
S&P 500 Most Active Stocks: Nov. 13, 2026 Session
Yahoo Finance
·
1 hour ago
Goldman Sachs sees upside for S&P 500 in 2027 — even as earnings growth slows
FOREX.com
·
1 hour ago
S&P 500 forecast: SPX struggles for direction ahead of PPI data
www.tokenpost.com
·
1 hour ago
Bitcoin Fell in 92% of S&P 500’s Worst 5% Return Periods Since 2022
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Florida, United States
SectorHealth Care
IndustryBiotechnology
Websitesab.bio